The Enterprise Value as of December 2025 (TTM) for JW (Cayman) Therapeutics Co. Ltd (JWCTF) is 886.52M

According to JW (Cayman) Therapeutics Co. Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 886.52M. This represents a change of 154.42% compared to the average of 348.44M of the last 4 quarters.

JW (Cayman) Therapeutics Co. Ltd (JWCTF) Historical Enterprise Value (quarterly & annually)

How has JWCTF Enterprise Value performed in the past?

The mean historical Enterprise Value of JW (Cayman) Therapeutics Co. Ltd over the last ten years is 1.74B. The current 886.52M Enterprise Value has changed 5.00% with respect to the historical average. Over the past ten years (40 quarters), JWCTF's Enterprise Value was at its highest in in the December 2018 quarter at 7.19B. The Enterprise Value was at its lowest in in the January 2018 quarter at 0.

JW (Cayman) Therapeutics Co. Ltd (JWCTF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of JW (Cayman) Therapeutics Co. Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

JW (Cayman) Therapeutics Co. Ltd (JWCTF) Average Enterprise Value

How has JWCTF Enterprise Value performed in the past?

The current Enterprise Value of JW (Cayman) Therapeutics Co. Ltd (JWCTF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

JW (Cayman) Therapeutics Co. Ltd (JWCTF) Enterprise Value vs. Peers

How is JWCTF’s Enterprise Value compared to its peers?

JW (Cayman) Therapeutics Co. Ltd’s Enterprise Value is greater than Molecular Partners AG (46.83M), greater than Santhera Pharmaceuticals Holding AG (217.04M), greater than Brii Biosciences Limited (-453427127.87), greater than Genfit S.A. (260.57M), greater than Innate Pharma S.A. (128.18M), greater than NervGen Pharma Corp. (438.78M), greater than NDT Pharmaceuticals Inc. (158.40M), greater than Botanix Pharmaceuticals Limited (172.49M), greater than Scancell Holdings plc (104.92M), greater than YourWay Cannabis Brands Inc. (3.28M),

Build a custom stock screener for JW (Cayman) Therapeutics Co. Ltd (JWCTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like JW (Cayman) Therapeutics Co. Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

JW (Cayman) Therapeutics Co. Ltd (JWCTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like JW (Cayman) Therapeutics Co. Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.